New app aims to boost cystic fibrosis treatment adherence

NCT ID NCT07031323

Recruiting now Symptom relief Sponsor: Boston Children's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a smartphone app called OnTrackCF, designed to help adults with cystic fibrosis remember to take their CFTR modulator medication and track their symptoms. The app sends up to 3 daily support messages and shows users their adherence levels. Researchers want to see if the app is easy to use, acceptable, and engaging for 60 adults with CF. The study does not test a new drug, but a behavioral tool to support existing treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OnTrackCF smartphone app (behavioral intervention)
What this could lead to: If successful, this app could help people with cystic fibrosis better manage their daily medication and symptoms, improving adherence and quality of life.
What could go wrong: This is a small, early feasibility study with only 60 participants, so results may not apply to everyone. The app's benefits depend on user engagement and may not lead to long-term health improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS (CF) CYSTIC FIBROSIS - COMPLETE

Contacts and locations

Locations

Boston Children's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Johns Hopkins University
NOT_YET_RECRUITING

Baltimore, Maryland, 21218, United States
University of Alabama-Birmingham
NOT_YET_RECRUITING

Birmingham, Alabama, 35233, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.